TrialPanorama/TrialPanorama-database huggingface dataset:
Study 31784904 — Predictive Biomarker (PRD): ITGB2 mRNA
Genes: ITGB2; CD18; MFI7
Study 31784904 — Predictive Biomarker (PRD): LOX mRNA
Genes: LOX
Study 31784904 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Adrenomedullin
Genes: ADM; AM
Study 31784904 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 17102644 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study 26782102 — Surrogate Endpoint (SUR): Blood pressure
Study 25237048 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 17664057 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 17664057 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 17664057 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 30878999 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 30878999 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study 30878999 — Surrogate Endpoint (SUR): Serum calcium
Study 9249123 — Surrogate Endpoint (SUR): Blood pressure
Study 8424497 — Surrogate Endpoint (SUR): Blood pressure
Study 24024323 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 24024323 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 21401941 — Predictive Biomarker (PRD): CNP mRNA
Genes: CNP
Study 1371323 — Surrogate Endpoint (SUR): Serum triglycerides
Study 9175948 — Surrogate Endpoint (SUR): Serum creatinine
Study 1493229 — Pharmacodynamic Biomarker (PDY): Mismatch negativity
Study 27144905 — Surrogate Endpoint (SUR): Serum uric acid
Study 10950411 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study 29726071 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 23924290 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 10867042 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 9434064 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-B
Genes: AS
Study 15840055 — Surrogate Endpoint (SUR): Bone mineral density
Study 7846294 — Safety Biomarker (SAF): CCKAR
Study 31721026 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31721026 — Surrogate Endpoint (SUR): Serum creatinine
Study 26362578 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 26362578 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 12509613 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 11100963 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study 26961114 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 17681027 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 17681027 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 28968138 — Surrogate Endpoint (SUR): Hemagglutination inhibition antibody
Study 26223345 — Monitoring Biomarker (MOI): HBV DNA
Study 17940203 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 2192098 — Surrogate Endpoint (SUR): Blood pressure
Study 22778317 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 18275764 — Surrogate Endpoint (SUR): Blood pressure
Study 15818105 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 15818105 — Surrogate Endpoint (SUR): Serum creatinine
Study 7793406 — Surrogate Endpoint (SUR): Blood pressure
Study 29878947 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study 24824548 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31808278 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 29110753 — Surrogate Endpoint (SUR): Blood pressure
Study 23816967 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 22866006 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 18752281 — Surrogate Endpoint (SUR): Bone mineral density
Study 17531723 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 3003729 — Surrogate Endpoint (SUR): Blood pressure
Study 3003729 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 29789130 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 21765345 — Safety Biomarker (SAF): Reactive oxygen species
Study 21765345 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 18506008 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 10617696 — Predictive Biomarker (PRD): MAS1 mRNA
Genes: MAS1; MAS
Study 26517576 — Predictive Biomarker (PRD): EVL mRNA
Genes: EVL; RNB6
Study 16883904 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 7910472 — Surrogate Endpoint (SUR): Blood pressure
Study 26417059 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 9022561 — Surrogate Endpoint (SUR): Blood pressure
Study 302028 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TNS1 mRNA
Genes: TNS1; TNS
Study 29179766 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 29880288 — Surrogate Endpoint (SUR): Blood pressure
Study 27823681 — Surrogate Endpoint (SUR): Serum creatinine
Study 18665826 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 15942550 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 12843352 — Surrogate Endpoint (SUR): Blood pressure
Study 10770343 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 1815423 — Surrogate Endpoint (SUR): Blood pressure
Study 6139422 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study 6139422 — Surrogate Endpoint (SUR): Serum testosterone
Study 27009061 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 19395584 — Predictive Biomarker (PRD): CNP mRNA
Genes: CNP
Study 19395584 — Surrogate Endpoint (SUR): Blood pressure
Study 19395584 — Pharmacodynamic Biomarker (PDY): Cyclic guanosine monophosphate
Study 11208829 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study 11208829 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 7848401 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 7848401 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 8857250 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 8857250 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study 8857250 — Surrogate Endpoint (SUR): Serum calcium
Study 17962589 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 10652038 — Surrogate Endpoint (SUR): Serum potassium
Study 6494106 — Surrogate Endpoint (SUR): Blood pressure
Study 26346122 — Safety Biomarker (SAF): Hyaluronic acid
Study 23707331 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 23707331 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 18257813 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 18257813 — Surrogate Endpoint (SUR): Serum calcium
Study 18257813 — Surrogate Endpoint (SUR): Serum intact parathyroid hormone
Study 18257813 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study 31207169 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study 15844579 — Predictive Biomarker (PRD): SPN mRNA
Genes: SPN; CD43
Study 15844579 — Predictive Biomarker (PRD): PNP mRNA
Genes: PNP; NP
Study 15844579 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 15844579 — Safety Biomarker (SAF): Th2 cell
Study 2503375 — Surrogate Endpoint (SUR): Blood pressure
Study 20927554 — Monitoring Biomarker (MOI): HBV DNA
Study 11771654 — Surrogate Endpoint (SUR): Bone mineral density
Study 28449205 — Surrogate Endpoint (SUR): Blood pressure
Study 28449205 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 23727002 — Predictive Biomarker (PRD): TLR9
Genes: CD289
Study 21732272 — Predictive Biomarker (PRD): NPY mRNA
Genes: NPY
Study 8550249 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study 744812 — Surrogate Endpoint (SUR): Blood pressure
Study 23490325 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 21806770 — Surrogate Endpoint (SUR): Blood pressure
Study 21806770 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 15309425 — Surrogate Endpoint (SUR): Bone mineral density
Study 31960907 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 25636288 — Predictive Biomarker (PRD): MXD1 mRNA
Genes: MXD1; MAD
Study 15639169 — Surrogate Endpoint (SUR): Blood pressure
Study 12860725 — Predictive Biomarker (PRD): CCR1 mRNA
Genes: CCR1; CMKBR1; CMKR1; SCYAR1
Study 12860725 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 9275690 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31122212 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 29789507 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 29789507 — Surrogate Endpoint (SUR): Blood pressure
Study 27426245 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 27426245 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 9620901 — Predictive Biomarker (PRD): CDA mRNA
Genes: CDA; CDD
Study 2590626 — Predictive Biomarker (PRD): CBS mRNA
Genes: CBS
Study 28343676 — Monitoring Biomarker (MOI): Matrix metalloproteinase 8
Genes: MMP8; CLG1
Study 11230853 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 29465583 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 29465583 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 16014882 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 12201869 — Monitoring Biomarker (MOI): HBV DNA
Study 10885834 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 8943865 — Predictive Biomarker (PRD): CD2 mRNA
Genes: CD2; SRBC
Study 30280328 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 27744075 — Predictive Biomarker (PRD): AKT1 mRNA
Genes: AKT1; PKB; RAC
Study 9816650 — Surrogate Endpoint (SUR): Blood pressure
Study 31870415 — Surrogate Endpoint (SUR): Blood pressure
Study 23953069 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 9585282 — Surrogate Endpoint (SUR): Blood pressure
Study 11601118 — Surrogate Endpoint (SUR): Blood pressure
Study 2297284 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 29410545 — Predictive Biomarker (PRD): DCC mRNA
Genes: DCC; IGDCC1
Study 26802800 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 24512061 — Predictive Biomarker (PRD): DRD1 mRNA
Genes: DRD1
Study 24512061 — Predictive Biomarker (PRD): DRD2 mRNA
Genes: DRD2
Study 24512061 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 7837401 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 21700945 — Surrogate Endpoint (SUR): Blood pressure
Study 30415507 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 24402830 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 577889 — Predictive Biomarker (PRD): HDC mRNA
Genes: HDC
Study 31029925 — Surrogate Endpoint (SUR): Blood pressure
Study 31029925 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 25079040 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25079040 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 7661384 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 7661384 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 12370220 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 23154555 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 19922895 — Surrogate Endpoint (SUR): Blood pressure
Study 29516699 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 27716253 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 27716253 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 23835817 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 21183910 — Predictive Biomarker (PRD): ROS1
Genes: MCF3; ROS; c-ros-1
Study 21183910 — Predictive Biomarker (PRD): LPO mRNA
Genes: LPO; SAPX
Study 6368491 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 29384173 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 27019421 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 7576966 — Predictive Biomarker (PRD): TH mRNA
Genes: TH; TYH
Study 29658370 — Surrogate Endpoint (SUR): Blood pressure
Study 8535554 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 8535554 — Surrogate Endpoint (SUR): Blood pressure
Study 28716046 — Surrogate Endpoint (SUR): Blood pressure
Study 2971708 — Predictive Biomarker (PRD): VIP mRNA
Genes: VIP
Study 26758438 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 26758438 — Safety Biomarker (SAF): Reactive oxygen species
Study 26758438 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 24766981 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 16077295 — Surrogate Endpoint (SUR): Blood pressure
Study 28549309 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 24448345 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 24448345 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 21262079 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 11156862 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 28216183 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 18320185 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31486915 — Predictive Biomarker (PRD): LHB mRNA
Genes: LHB
Study 26824413 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study 25225746 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 25225746 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 24029567 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 24029567 — Surrogate Endpoint (SUR): Serum uric acid
Study 24029567 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 20577147 — Surrogate Endpoint (SUR): Blood pressure
Study 29140772 — Predictive Biomarker (PRD): COPE mRNA
Genes: COPE
Study 20691130 — Safety Biomarker (SAF): Lactotransferrin
Genes: LTF; GIG12; LF
Study 16964522 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 8833706 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 8833706 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 2485264 — Surrogate Endpoint (SUR): Blood pressure
Study 31471173 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 29504981 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study 25034562 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 16555581 — Surrogate Endpoint (SUR): Blood pressure
Study 25446409 — Predictive Biomarker (PRD): C2 mRNA
Genes: C2
Study 25446409 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 17295723 — Surrogate Endpoint (SUR): Blood pressure
Study 10087798 — Surrogate Endpoint (SUR): Blood pressure
Study 28500554 — Predictive Biomarker (PRD): TNFSF10 mRNA
Genes: TNFSF10; APO2L; TRAIL
Study 15265162 — Surrogate Endpoint (SUR): Serum creatinine
Study 15265162 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study 1804605 — Predictive Biomarker (PRD): GPT mRNA
Genes: GPT; AAT1; GPT1
Study 1804605 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 1804605 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 27876358 — Predictive Biomarker (PRD): COL17A1 mRNA
Genes: COL17A1; BP180; BPAG2
Study 18551121 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 18551121 — Surrogate Endpoint (SUR): Blood pressure
Study 12455450 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 10483893 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 10483893 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 26121679 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 26121679 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 23330658 — Surrogate Endpoint (SUR): Blood pressure
Study 16050407 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study 16050407 — Surrogate Endpoint (SUR): Blood pressure
Study 12853792 — Predictive Biomarker (PRD): HAL mRNA
Genes: HAL; HIS
Study 10217357 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 10217357 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 7606988 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 348380 — Surrogate Endpoint (SUR): Blood pressure
Study 348380 — Surrogate Endpoint (SUR): Serum uric acid
Study 348380 — Surrogate Endpoint (SUR): Serum potassium
Study 348380 — Surrogate Endpoint (SUR): Serum creatinine
Study 31234865 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 31234865 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study 27102843 — Predictive Biomarker (PRD): Carbonic anhydrase IX
Genes: CA9; G250; MN
Study 20175876 — Predictive Biomarker (PRD): VIP mRNA
Genes: VIP
Study 20175876 — Surrogate Endpoint (SUR): Blood pressure
Study 18019664 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 18019664 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 18019664 — Monitoring Biomarker (MOI): Procalcitonin
Study 16145697 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 8886347 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 23567483 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 23567483 — Predictive Biomarker (PRD): SELENBP1 mRNA
Genes: SELENBP1; SBP
Study 20518009 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 18454862 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 16567267 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 16567267 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 3094617 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 31664766 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31664766 — Predictive Biomarker (PRD): BATF mRNA
Genes: BATF
Study 31664766 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 31664766 — Predictive Biomarker (PRD): LAG3 mRNA
Genes: LAG3; FDC
Study 31664766 — Predictive Biomarker (PRD): SOCS3 mRNA
Genes: SOCS3; CIS3; SSI3
Study 31664766 — Predictive Biomarker (PRD): IL21
Genes: Za11; IL-21
Study 31664766 — Pharmacodynamic Biomarker (PDY): Antidrug antibody
Study 20191568 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study 16970214 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 16970214 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 16970214 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 15595305 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 30094437 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24920942 — Surrogate Endpoint (SUR): Blood pressure
Study 22419728 — Surrogate Endpoint (SUR): Bone mineral density
Study 20641122 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 20641122 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19370949 — Surrogate Endpoint (SUR): Blood pressure
Study 15936878 — Predictive Biomarker (PRD): GYPC mRNA
Genes: GYPC; GLPC; GPC
Study 15936878 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 31698917 — Predictive Biomarker (PRD): PYCARD mRNA
Genes: PYCARD; ASC; CARD5; TMS1
Study 24047539 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 24047539 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 16696744 — Surrogate Endpoint (SUR): Bone mineral density
Study 11397884 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 11397884 — Surrogate Endpoint (SUR): Bone mineral density
Study 9777817 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study 7889894 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 7889894 — Surrogate Endpoint (SUR): Blood pressure
Study 7889894 — Surrogate Endpoint (SUR): Serum triglycerides
Study 7889894 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study 3065571 — Surrogate Endpoint (SUR): Blood pressure
Study 31732234 — Surrogate Endpoint (SUR): Blood pressure